The enhanced tumor inhibitory effects of gefitinib and L-ascorbic acid combination therapy in non-small cell lung cancer cells.

Lee, Kyoung Eun; Hahm, Eunsil; Bae, Seyeon; Kang, Jae Seung; Lee, Wang Jae.

Afiliação

Lee KE; Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Ewha Womans University, Seoul 07985, Republic of Korea.
Hahm E; Department of Anatomy and Tumor Immunity Medical Research Center, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.
Bae S; Department of Anatomy and Tumor Immunity Medical Research Center, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.
Kang JS; Department of Anatomy and Tumor Immunity Medical Research Center, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.
Lee WJ; Department of Anatomy and Tumor Immunity Medical Research Center, College of Medicine, Seoul National University, Seoul 03080, Republic of Korea.

Oncol Lett ; 14(1): 276-282, 2017 Jul.

Article em En | MEDLINE | ID: mdl-28693165